Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Net Income (Common)
Theravance Biopharma Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Net Income (Common)
-$55.2m
|
CAGR 3-Years
42%
|
CAGR 5-Years
24%
|
CAGR 10-Years
10%
|
See Also
What is Theravance Biopharma Inc's Net Income (Common)?
Net Income (Common)
-55.2m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Net Income (Common) amounts to -55.2m USD.
What is Theravance Biopharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%
The average annual Net Income (Common) growth rates for Theravance Biopharma Inc have been 42% over the past three years , 24% over the past five years , and 10% over the past ten years .